Too early to switch to mainland bird flu vaccine, says health chief
The health chief says it is too early to decide whether Hong Kong should switch from using a Dutch-made bird flu vaccine to one from the mainland.
Secretary for Food and Health York Chow Yat-ngok said University of Hong Kong test results on the efficacy of the Dutch vaccine on virus samples taken at four wet markets in June were 'not conclusive'.
Hong Kong has been using a H5N2 vaccine made by animal health care company InterVet from the Netherlands since the government started a vaccination programme for local farms in 2003.
InterVet's vaccine appeared to be effective until the H5 virus killed 200 chickens at a farm in Yuen Long on Monday and early Tuesday.
There have since been calls for the government to consider switching to a mainland-made H5N1 vaccine.
Some of the birds that died at the Yuen Long farm had been vaccinated against bird flu - giving rise to fears that the virus may have mutated, and that the vaccine might be losing its effectiveness. The farm outbreak came six months after Hong Kong detected the virus at four wet markets in June, prompting a 21-day shutdown and a ban on overnight stocking of live chickens in markets.